Position history for JPMORGAN CHASE & CO's holdings in RELMADA THERAPEUTICS INC
JPMORGAN CHASE & CO previously held 0 shares of RLMD (RELMADA THERAPEUTICS INC), worth $0 as of 2025-Q3.
Final Value
$0
Final Shares
0
Total Value Change
-$19,604
Total Shares Change
-37,700
Other major holders of RLMD: UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Exited |
| 0 |
-100.0% |
| $0 |
| 0.0% |
| $1.88 |
0 |
| 2025-Q2 | Increased | 5,103 | +3129.8% | $3,063 | 0.0% | $0.61 | 15 |
| 2025-Q1 | Decreased | 158 | -99.6% | $43 | 0.0% | $0.30 | 0 |
| 2024-Q4 | New | 37,700 | - | $19,604 | 0.0% | $0.46 | 29 |